| ID | 1750 |
| No | 1750 |
| Brand Name | LUCIMAVA |
| Ingredients | MAVACAMTEN 2.5 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 60'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF ADULTS WITH SYMPTOMATIC NEW YORK HEART ASSOCIATION CLASS II-III OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | BLUE - WHITE CAPSULE CONTAINS WHITE POWDER |
| Note | |
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 09 L 1198/24 |
| FDD Registration Date | 24/09/2024 |
| Expiry Date | 23/09/2029 |